Haemonetics Corp. named Robert Abernathy to its board.
Abernathy is the former chairman and CEO of Halyard Health Inc.
Haemonetics names board member
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Haemonetics Corp. named Robert Abernathy to its board.
Abernathy is the former chairman and CEO of Halyard Health Inc.